Fintel reports that on December 11, 2024, RBC Capital downgraded their outlook for CEMEX, S.A.B. de C.V. - Depositary Receipt ...

RBC Capital analyst Gregory Renza maintained a Hold rating on Spruce Biosciences (SPRB – Research Report) yesterday and set a price target of ...

Inditex recently reported softer-than-expected third-quarter results, prompting RBC to revise its earnings forecasts for the ...

In a report released yesterday, Jonathan Atkin from RBC Capital maintained a Buy rating on Equinix (EQIX – Research Report), with a price ...

Fintel reports that on December 10, 2024, RBC Capital downgraded their outlook for BrightSphere Investment Group (NYSE:BSIG) ...

Mobileye Global (MBLY) stock rose about 6% on Monday after RBC Capital said that the company could be close to winning a ...

RBC Capital Markets upgrades Marsh & McLennan stock to Outperform, citing strong growth potential and valuation compared to peers.

Find insight on Novo Nordisk, Hikma Pharmaceuticals, Sonic Healthcare and more in the latest Market Talks covering the Health ...

Analysts raise Ollie's price targets, citing strong earnings, unit growth, and market share potential despite challenges.

Exxon Mobil Corp. will raise capital spending next year as it adds the $60 billion purchase of Pioneer Natural Resources Co.

Despite these concerns, RBC noted that the market reaction has been disproportionate, with TotalEnergies’ market ...

From M&A and tariffs to new health leaders, here are the top issues for the medical device industry to watch when ...